Search

everythinglearnresearchcommunity

for

Search:↓

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.